Augusto M. Carvalho

Salvador, BA, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Magnetic resonance imaging in the diagnosis of HTLV-1-associated myelopathy.

Magnetic resonance imaging in the diagnosis of HTLV-1-associated myelopathy.

Journal: Arquivos de neuro-psiquiatria

Published: July 22, 2025

The Leishmania Skin Test Predicts Clinic-Immunologic and Therapeutic Outcomes in Cutaneous Leishmaniasis.

The Leishmania Skin Test Predicts Clinic-Immunologic and Therapeutic Outcomes in Cutaneous Leishmaniasis.

Journal: Pathogens (Basel, Switzerland)

Published: October 11, 2024

Use of topical rSm29 in combination with intravenous meglumine antimoniate in the treatment of cutaneous leishmaniasis: A randomized controlled trial.

Use of topical rSm29 in combination with intravenous meglumine antimoniate in the treatment of cutaneous leishmaniasis: A randomized controlled trial.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: March 25, 2024

Disseminated Leishmaniasis, a Severe Form of Leishmania braziliensis Infection.

Disseminated Leishmaniasis, a Severe Form of Leishmania braziliensis Infection.

Journal: Emerging infectious diseases

Published: February 26, 2024

In Situ versus Systemic Immune Response in the Pathogenesis of Cutaneous Leishmaniasis.

In Situ versus Systemic Immune Response in the Pathogenesis of Cutaneous Leishmaniasis.

Journal: Pathogens (Basel, Switzerland)

Published: January 10, 2024

Serodiagnosis and therapeutic monitoring of New-World tegumentary leishmaniasis using synthetic type-2 glycoinositolphospholipid-based neoglycoproteins.

Serodiagnosis and therapeutic monitoring of New-World tegumentary leishmaniasis using synthetic type-2 glycoinositolphospholipid-based neoglycoproteins.

Journal: Emerging microbes & infections

Published: August 30, 2022

TNF-induced metalloproteinase-9 production is associated with neurological manifestations in HTLV-1-infected individuals.

TNF-induced metalloproteinase-9 production is associated with neurological manifestations in HTLV-1-infected individuals.

Journal: Frontiers in immunology

Published: May 27, 2022

Protection and Pathology in Leishmania braziliensis Infection.

Protection and Pathology in Leishmania braziliensis Infection.

Journal: Pathogens (Basel, Switzerland)

Published: March 10, 2022

Immune Response to LinB13, a Lutzomyia Intermedia Salivary Protein Correlates With Disease Severity in Tegumentary Leishmaniasis.

Immune Response to LinB13, a Lutzomyia Intermedia Salivary Protein Correlates With Disease Severity in Tegumentary Leishmaniasis.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: October 23, 2021

Microbiota instruct IL-17A-producing innate lymphoid cells to promote skin inflammation in cutaneous leishmaniasis.

Microbiota instruct IL-17A-producing innate lymphoid cells to promote skin inflammation in cutaneous leishmaniasis.

Journal: PLoS pathogens

Published: June 01, 2021

Inhibition of gamma-secretase activity without interfering in Notch signalling decreases inflammatory response in patients with cutaneous leishmaniasis.

Inhibition of gamma-secretase activity without interfering in Notch signalling decreases inflammatory response in patients with cutaneous leishmaniasis.

Journal: Emerging microbes & infections

Published: May 19, 2021

Anti-Leishmania IgG is a marker of disseminated leishmaniasis caused by Leishmania braziliensis.

Anti-Leishmania IgG is a marker of disseminated leishmaniasis caused by Leishmania braziliensis.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: December 01, 2020

Showing 1-12 of 27

Last Updated: 09/26/2026